Jason Evans
Nurenyx Inc.
Jason Evans – Chairman of the Business Council for Artificial Intelligence
Jason Evans, a dynamic leader and visionary in the field of artificial intelligence, currently serves as the Chairman of the Business Council for Artificial Intelligence within the International Trade Council. His profound business acumen, particularly in areas like international trade, supply chains, transparency, and logistics, has propelled him to the forefront of the industry.
As the Co-Founder, President, and CEO of Nurenyx Inc., Jason has made significant contributions to the healthcare technology and clinical research sector. Nurenyx is renowned for its innovative solutions, harnessing the power of artificial intelligence (AI), blockchain, gamification, and immersive extended reality (XR) simulations. These technologies are revolutionizing clinical trials, enhancing participant engagement, improving study efficiency, and ensuring secure and data-driven research.
Jason’s journey in this industry began with identifying the pressing challenges and opportunities within healthcare and clinical research. Leveraging his impressive educational background, which includes a Bachelor’s degree in Microbiology/Immunology and certification as a Lean Six Sigma Black Belt, he combined expertise in technologies like .NET, AI, machine learning, and XR. This fusion of knowledge laid the foundation for Nurenyx’s groundbreaking solutions. He also possesses a Master’s of Management Innovation & Entrepreneurship degree.
One of Jason’s proudest accomplishments is Nurenyx’s decentralized clinical studies software, empowering pharmaceutical companies, contract research organizations (CROs), and academia to create customized mobile apps for clinical studies. This innovation has significantly streamlined the research process, benefiting both participants and organizations involved in medical research.
Nurenyx’s remarkable journey is closely aligned with esteemed institutions such as Queen’s University Startup Runway Program, the University of Toronto’s Health Innovations Hub, and the Ted Rogers Centre for Heart Research Entrepreneurship for Cardiovascular Health Opportunities Program. Their affiliation with innovation powerhouses like MIT Sandbox Dive into Healthcare Innovation, NVIDIA Inception Program, and major tech companies underscores their commitment to pioneering advancements in healthcare technology.
Looking ahead, Jason envisions the clinical studies industry undergoing a profound transformation in the next 5-10 years. This transformation will prioritize patient-centric approaches through virtual trials and mobile app engagement, reduce costs through decentralized models, and prioritize data security with technologies like blockchain. Artificial intelligence and predictive analytics will optimize various aspects of clinical trials, further streamlining drug development.
Beyond his professional pursuits, Jason is a music enthusiast and a globetrotter who seeks new horizons through travel. He values the connections he shares with family and friends, making life’s adventures all the more meaningful.
Jason’s passion for innovation and his commitment to improving healthcare technology make him a true trailblazer in the field of artificial intelligence.